Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Role of Allogeneic Stem Cell Transplant in Myeloma Treatment w/ Dr. Komanduri

  • Broadcast in Health
  • 0 comments
CureTalks

CureTalks

×  

Follow This Show

If you liked this show, you should follow CureTalks.
h:350019
s:7843345
archived

The role of allogeneic stem cell transplantation is evolving in the paradigm of myeloma treatment. Despite its therapeutic potential of a myeloma cure, the use of donor stem cell transplantation or allogeneic transplantation is highly debated in the medical field due to the safety risks and rate of relapse. We are talking to Dr. Komanduri to better understand allogeneic transplants, optimal timing and how to manage graft-versus-myeloma effect for improved efficacy and safety.

Dr. Komanduri is Medical Director of the hematopoietic stem cell transplant program at the University of Miami Sylvester Cancer Center, one of the fastest growing programs in the country. 

RSVP HERE!

 

 

Comments

 comments